[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Boog et al., 1988 - Google Patents

Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.

Boog et al., 1988

View PDF
Document ID
17734849648960837316
Author
Boog C
Boes J
Melief C
Publication year
Publication venue
Journal of immunology (Baltimore, Md.: 1950)

External Links

Snippet

Two class I MHC mutant mouse strains, bm14 and bm13, differ from the strain of origin B6 in one and three amino acids in the alpha 1 and alpha 2 domains of the H-2Db molecule, respectively. These alterations result in specific failure to generate a CTL (Tc) response to …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Davignon et al. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2, 3 that participates in T lymphocyte-mediated killing.
US7432354B2 (en) Tumor antigen
ES2314196T3 (en) TUMOR ASSOCIATED PEPTIDES UNITED TO MHC MOLECULES.
Gambacorti-Passerini et al. Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells
AU652540B2 (en) T cell receptor peptides as therapeutics for autoimmune and malignant disease
JP6298101B2 (en) Method for activating helper T cells
AU2007298494B2 (en) Antigen specific multi epitope vaccines
US5705159A (en) Immunoreactive peptide sequence from a 43 KD human cancer antigen
Maryanski et al. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
ES2537323T3 (en) CDCA1 peptide and pharmaceutical agent comprising it
JPH07278193A (en) Antigen polypeptide relating to melanoma, its epitope, and melanoma vaccine
Raitakari et al. T cells in myeloma
Boog et al. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
Rao et al. Mapping of thyroglobulin epitopes: presentation of a 9mer pathogenic peptide by different mouse MHC class II isotypes
WO2019086507A1 (en) Immunotherapeutic methods for treating and/or preventing lung cancer
AU669329B2 (en) Method of modulating mammalian T-cell response
CN109311955A (en) A kind of new tumour-specific polypeptides and its application
HUT67859A (en) Antitumour method and antitumor agent
Brocke et al. Inhibition of T cell proliferation specific for acetylcholine receptor epitopes related to myasthenia gravis with antibody to T cell receptor or with competitive synthetic polymers
Yamaki et al. Characterization of rat T cell subset antigen by monoclonal antibody
Wettstein Murine minor histocompatibility antigens detected by helper T cells. Recognition of an endogenous peptide.
Walker et al. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
Schmidt et al. Identification of murine H-2Db histocompatibility antigens in cells transfected with cloned H-2 genes
Parmiani et al. The undefined relationship between tumor antigens and histocompatibility antigens on cancer cells
Gambacorti-Passerini et al. Human CD4 lymphocytes specifically recognize a peptide